These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 7913043

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
    Svensson A, Carlsson A, Carlsson ML.
    J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
    [Abstract] [Full Text] [Related]

  • 3. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM, Anderson JJ, Boldry RC, Kuo S, Chase TN.
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS, Starr BS.
    Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
    [Abstract] [Full Text] [Related]

  • 9. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine.
    Starr MS, Starr BS.
    J Neural Transm Park Dis Dement Sect; 1993 Apr; 6(3):215-26. PubMed ID: 7907216
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock.
    Smith SE, Acton L, Sharp T.
    Psychopharmacology (Berl); 1997 Sep; 133(1):85-94. PubMed ID: 9335085
    [Abstract] [Full Text] [Related]

  • 11. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A, Castellano C, Felici A, Cabib S, Caccia S, Oliverio A.
    Eur J Pharmacol; 1996 Jul 11; 308(1):1-12. PubMed ID: 8836626
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
    Boldry RC, Chase TN, Engber TM.
    J Pharmacol Exp Ther; 1993 Dec 11; 267(3):1454-9. PubMed ID: 7903390
    [Abstract] [Full Text] [Related]

  • 14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF, Sheng J.
    J Pharmacol Exp Ther; 1993 Jan 11; 264(1):221-5. PubMed ID: 8093726
    [Abstract] [Full Text] [Related]

  • 15. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP, Rogawski MA.
    Behav Brain Res; 1995 Oct 11; 70(2):145-51. PubMed ID: 8561905
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A, Kulkarni SK.
    Psychopharmacology (Berl); 1992 Oct 11; 109(4):477-83. PubMed ID: 1365866
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.